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Identity 
Other names: I2PP2A, I-2PP2A (Phosphatase 2A 
inhibitor); TAF-IBETA (Template activating factor I)
PHAPII (HLA-DR associated protein II); IGAAD 
(Inhibitor of granzyme A-activated Dnase) 
HGNC (Hugo): SET 
Location: 9q34 
Local order: from centromere to telomere: SET, 
ABL1, NUP214 (alias CAN), NOTCH1 (alias TAN1). 
DNA/RNA 
Description 
SET encompasses 6.81 kb on the genomic DNA; 8 
exons. 
Transcription 
2577 bp mRNA. 
Protein 
Description 
Two isoforms; isoform 1 (TAF1 alpha) 290 amino 
acids, 33.5 kDa; isoform 2 (TAF1 beta) - 277 amino 
acids, 23.1 kDa. 
Expression 
Widely expressed; highly expressed in Wilms' tumor. 
Localisation 
Cytoplasmic and nuclear; in the cytoplasm, found both 
in the cytosol and associated with the endoplasmic 
reticulum. 
Function 
Multitasking protein, involved in apoptosis, 
transcription, nucleosome assembly, and histone 
binding; potent inhibitor of protein phosphatase 2A; 
inhibits also EP300/CREBBP and PCAF-mediated 
acetylation of histones (HAT) - predominantly H4 - and 
nucleosomes; HAT inhibition leads to silencing of 
HAT-dependent transcription and prevents active 
demethylation of DNA. 
Homology 
Belongs to the nucleosome assembly protein (NAP) 
family. 
Implicated in 
t(9;9)(q34;q34)  --> SET-NUP214 (alias 
CAN) 
Disease 
Acute undifferentiated leukemia (AUL); only one case 
described so far. 
Cytogenetics 
Normal karyotype; may be overlooked. 
Hybrid/Mutated gene 
5' SET - 3' NUP214. 
Abnormal protein 
The SET-NUP214 (alias CAN) fusion protein consists 
of almost the whole SET protein fused to the C-
terminus of NUP214. 
Oncogenesis 
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